Concepts (181)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myofibroblasts | 8 | 2024 | 208 | 4.110 |
Why?
|
| Ribonuclease, Pancreatic | 3 | 2024 | 150 | 2.370 |
Why?
|
| Cyclooxygenase 2 | 6 | 2020 | 599 | 2.180 |
Why?
|
| Protein Kinase C | 8 | 2020 | 1197 | 1.810 |
Why?
|
| Colon | 9 | 2020 | 1770 | 1.570 |
Why?
|
| Tumor Necrosis Factor-alpha | 7 | 2023 | 4343 | 1.250 |
Why?
|
| HSP27 Heat-Shock Proteins | 2 | 2016 | 67 | 1.090 |
Why?
|
| Bradykinin | 3 | 2020 | 208 | 1.050 |
Why?
|
| Colonoscopy | 3 | 2018 | 1360 | 0.680 |
Why?
|
| Personnel Selection | 1 | 2020 | 189 | 0.640 |
Why?
|
| Cultural Diversity | 1 | 2020 | 365 | 0.560 |
Why?
|
| Cell Communication | 2 | 2024 | 1625 | 0.540 |
Why?
|
| Immunocompetence | 1 | 2015 | 134 | 0.500 |
Why?
|
| Colorectal Neoplasms | 4 | 2024 | 6748 | 0.490 |
Why?
|
| Colitis | 1 | 2023 | 1211 | 0.470 |
Why?
|
| Cell Movement | 2 | 2016 | 5166 | 0.470 |
Why?
|
| Colonic Polyps | 1 | 2018 | 540 | 0.450 |
Why?
|
| Colectomy | 1 | 2018 | 668 | 0.450 |
Why?
|
| Rectal Neoplasms | 4 | 2024 | 1165 | 0.440 |
Why?
|
| Minority Groups | 1 | 2020 | 1197 | 0.430 |
Why?
|
| Injections | 2 | 2015 | 831 | 0.430 |
Why?
|
| Intestinal Fistula | 1 | 2013 | 140 | 0.420 |
Why?
|
| Abdominal Abscess | 1 | 2013 | 151 | 0.400 |
Why?
|
| Diverticulitis, Colonic | 1 | 2013 | 129 | 0.400 |
Why?
|
| Diverticulitis | 1 | 2014 | 177 | 0.390 |
Why?
|
| Intestinal Perforation | 1 | 2013 | 252 | 0.390 |
Why?
|
| Lactones | 2 | 2003 | 320 | 0.360 |
Why?
|
| Anus Neoplasms | 2 | 2024 | 327 | 0.320 |
Why?
|
| Lysophospholipids | 1 | 2011 | 339 | 0.310 |
Why?
|
| Students, Medical | 1 | 2020 | 1878 | 0.290 |
Why?
|
| Treatment Refusal | 2 | 2020 | 425 | 0.280 |
Why?
|
| Laparoscopy | 1 | 2018 | 2149 | 0.270 |
Why?
|
| Intestinal Mucosa | 5 | 2015 | 2991 | 0.250 |
Why?
|
| Phosphorylation | 6 | 2020 | 8294 | 0.250 |
Why?
|
| Lung Transplantation | 1 | 2014 | 1271 | 0.240 |
Why?
|
| Mice, Inbred C57BL | 5 | 2023 | 21600 | 0.230 |
Why?
|
| Job Application | 1 | 2020 | 39 | 0.180 |
Why?
|
| Tight Junctions | 1 | 2003 | 309 | 0.180 |
Why?
|
| Internship and Residency | 1 | 2020 | 5775 | 0.180 |
Why?
|
| Duodenal Neoplasms | 1 | 2020 | 113 | 0.170 |
Why?
|
| Disease Models, Animal | 4 | 2023 | 17870 | 0.170 |
Why?
|
| Up-Regulation | 2 | 2012 | 4118 | 0.170 |
Why?
|
| Signal Transduction | 5 | 2024 | 23155 | 0.170 |
Why?
|
| Fibroblasts | 1 | 2009 | 4051 | 0.160 |
Why?
|
| Tumor Microenvironment | 2 | 2024 | 3695 | 0.160 |
Why?
|
| Cell Line | 5 | 2016 | 15645 | 0.160 |
Why?
|
| Goals | 1 | 2023 | 696 | 0.150 |
Why?
|
| Epithelial Cells | 4 | 2005 | 3668 | 0.150 |
Why?
|
| Hyperthermia, Induced | 1 | 2021 | 416 | 0.150 |
Why?
|
| Interleukin-10 | 1 | 2023 | 1162 | 0.150 |
Why?
|
| Protein Kinase C-epsilon | 4 | 2005 | 43 | 0.140 |
Why?
|
| Leiomyosarcoma | 1 | 2020 | 442 | 0.130 |
Why?
|
| Benzalkonium Compounds | 1 | 2015 | 21 | 0.130 |
Why?
|
| Genes, Neoplasm | 1 | 2017 | 371 | 0.130 |
Why?
|
| Peritoneal Neoplasms | 1 | 2021 | 689 | 0.120 |
Why?
|
| Mice | 6 | 2024 | 80264 | 0.120 |
Why?
|
| Mesothelioma | 1 | 2021 | 827 | 0.120 |
Why?
|
| Enzyme Activation | 2 | 2012 | 3602 | 0.120 |
Why?
|
| Stromal Cells | 1 | 2019 | 1301 | 0.110 |
Why?
|
| Los Angeles | 1 | 2014 | 238 | 0.110 |
Why?
|
| Phosphatidylinositols | 1 | 1994 | 286 | 0.110 |
Why?
|
| Blotting, Western | 2 | 2012 | 5055 | 0.110 |
Why?
|
| Carbachol | 4 | 2005 | 223 | 0.110 |
Why?
|
| Hirschsprung Disease | 1 | 2015 | 157 | 0.110 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2016 | 1755 | 0.110 |
Why?
|
| Bryostatins | 2 | 2003 | 24 | 0.110 |
Why?
|
| Postoperative Complications | 2 | 2024 | 15365 | 0.110 |
Why?
|
| Liver Neoplasms | 2 | 2021 | 4254 | 0.110 |
Why?
|
| Cost Savings | 1 | 2018 | 920 | 0.110 |
Why?
|
| Animals | 8 | 2024 | 166578 | 0.110 |
Why?
|
| Myosins | 1 | 1994 | 402 | 0.110 |
Why?
|
| Humans | 28 | 2024 | 746839 | 0.110 |
Why?
|
| Interleukin-6 | 1 | 2023 | 3161 | 0.110 |
Why?
|
| Immunoblotting | 1 | 2016 | 1653 | 0.110 |
Why?
|
| Ablation Techniques | 1 | 2015 | 244 | 0.100 |
Why?
|
| Enteric Nervous System | 1 | 2015 | 197 | 0.100 |
Why?
|
| Heat-Shock Proteins | 1 | 2016 | 799 | 0.100 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2012 | 191 | 0.100 |
Why?
|
| Macrolides | 2 | 2003 | 204 | 0.100 |
Why?
|
| Molecular Chaperones | 1 | 2016 | 736 | 0.100 |
Why?
|
| Chlorides | 2 | 2005 | 666 | 0.100 |
Why?
|
| Peritonitis | 1 | 2013 | 366 | 0.100 |
Why?
|
| Pertussis Toxin | 1 | 2011 | 174 | 0.090 |
Why?
|
| Lymphoma | 1 | 2020 | 1876 | 0.090 |
Why?
|
| Muscle, Smooth | 1 | 1994 | 922 | 0.090 |
Why?
|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2014 | 377 | 0.090 |
Why?
|
| Quantum Dots | 1 | 2012 | 168 | 0.090 |
Why?
|
| Propionates | 1 | 2011 | 175 | 0.090 |
Why?
|
| Receptor, Bradykinin B2 | 1 | 2009 | 24 | 0.090 |
Why?
|
| Feasibility Studies | 1 | 2020 | 5096 | 0.090 |
Why?
|
| Cells, Cultured | 4 | 2012 | 18911 | 0.090 |
Why?
|
| Membrane Proteins | 2 | 2004 | 7788 | 0.080 |
Why?
|
| Immunoprecipitation | 1 | 2012 | 874 | 0.080 |
Why?
|
| Isoxazoles | 1 | 2011 | 226 | 0.080 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2012 | 611 | 0.080 |
Why?
|
| Epidermal Growth Factor | 1 | 2012 | 695 | 0.080 |
Why?
|
| Fibrosis | 1 | 2016 | 2012 | 0.080 |
Why?
|
| MAP Kinase Signaling System | 1 | 2016 | 1481 | 0.080 |
Why?
|
| Hospitals, Community | 2 | 2021 | 360 | 0.080 |
Why?
|
| Colonic Neoplasms | 1 | 2020 | 2504 | 0.080 |
Why?
|
| Dinoprostone | 1 | 2011 | 598 | 0.080 |
Why?
|
| Regeneration | 1 | 2016 | 1491 | 0.070 |
Why?
|
| Male | 12 | 2021 | 351538 | 0.070 |
Why?
|
| Emergencies | 1 | 2013 | 1166 | 0.070 |
Why?
|
| Organ Transplantation | 1 | 2017 | 1129 | 0.070 |
Why?
|
| Female | 12 | 2021 | 382565 | 0.070 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2021 | 3986 | 0.070 |
Why?
|
| Neoplasm Staging | 4 | 2021 | 11078 | 0.060 |
Why?
|
| Drug Synergism | 1 | 2009 | 1734 | 0.060 |
Why?
|
| Sodium-Potassium-Chloride Symporters | 1 | 2005 | 101 | 0.060 |
Why?
|
| Cell Survival | 1 | 2015 | 5764 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2011 | 10750 | 0.060 |
Why?
|
| Adenocarcinoma | 3 | 2020 | 6300 | 0.060 |
Why?
|
| Retrospective Studies | 8 | 2024 | 78360 | 0.060 |
Why?
|
| Protein Biosynthesis | 1 | 2012 | 2108 | 0.060 |
Why?
|
| Guideline Adherence | 1 | 2014 | 2189 | 0.060 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 3790 | 0.060 |
Why?
|
| Crohn Disease | 1 | 2016 | 2244 | 0.060 |
Why?
|
| Antibodies, Monoclonal | 1 | 2020 | 9107 | 0.050 |
Why?
|
| Muscarinic Agonists | 1 | 2003 | 88 | 0.050 |
Why?
|
| Protein Kinase C-delta | 1 | 2002 | 114 | 0.050 |
Why?
|
| Perineum | 1 | 2024 | 208 | 0.050 |
Why?
|
| Survival Rate | 3 | 2021 | 12645 | 0.050 |
Why?
|
| Tritium | 1 | 2002 | 708 | 0.050 |
Why?
|
| Mannitol | 1 | 2002 | 180 | 0.050 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2002 | 254 | 0.050 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2016 | 2390 | 0.050 |
Why?
|
| RNA, Small Interfering | 1 | 2011 | 3453 | 0.050 |
Why?
|
| Cell Membrane Permeability | 1 | 2003 | 581 | 0.050 |
Why?
|
| Databases, Factual | 3 | 2021 | 7816 | 0.050 |
Why?
|
| Protein Transport | 2 | 2005 | 1962 | 0.050 |
Why?
|
| Early Detection of Cancer | 1 | 2014 | 3128 | 0.040 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2002 | 576 | 0.040 |
Why?
|
| Membrane Potentials | 1 | 2003 | 1103 | 0.040 |
Why?
|
| Antineoplastic Agents | 1 | 2002 | 13584 | 0.040 |
Why?
|
| Pelvis | 1 | 2024 | 730 | 0.040 |
Why?
|
| Iodine Radioisotopes | 1 | 2002 | 1029 | 0.040 |
Why?
|
| Middle Aged | 6 | 2020 | 214698 | 0.040 |
Why?
|
| Electric Impedance | 1 | 2003 | 732 | 0.040 |
Why?
|
| Biological Transport | 1 | 2002 | 2079 | 0.040 |
Why?
|
| United States | 3 | 2020 | 70474 | 0.040 |
Why?
|
| Hepatectomy | 1 | 2021 | 549 | 0.040 |
Why?
|
| Docosahexaenoic Acids | 1 | 2003 | 892 | 0.030 |
Why?
|
| Patient Preference | 1 | 2023 | 892 | 0.030 |
Why?
|
| Intestines | 1 | 2004 | 1894 | 0.030 |
Why?
|
| Surgical Flaps | 1 | 2024 | 1659 | 0.030 |
Why?
|
| Lithium Chloride | 1 | 1994 | 82 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2011 | 5613 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2004 | 2860 | 0.030 |
Why?
|
| Intestine, Small | 1 | 2020 | 1187 | 0.030 |
Why?
|
| Tetradecanoylphorbol Acetate | 2 | 2005 | 817 | 0.030 |
Why?
|
| Time Factors | 1 | 2015 | 39639 | 0.030 |
Why?
|
| Propensity Score | 1 | 2020 | 1848 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2002 | 3903 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2003 | 3700 | 0.030 |
Why?
|
| Rectum | 1 | 2015 | 898 | 0.020 |
Why?
|
| Neoadjuvant Therapy | 1 | 2021 | 2788 | 0.020 |
Why?
|
| Muscle Contraction | 1 | 1994 | 1202 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2021 | 8521 | 0.020 |
Why?
|
| Cattle | 1 | 1994 | 3840 | 0.020 |
Why?
|
| Trachea | 1 | 1994 | 1082 | 0.020 |
Why?
|
| Insurance, Health | 1 | 2020 | 2476 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2005 | 11870 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2017 | 4823 | 0.020 |
Why?
|
| Sex Factors | 1 | 2020 | 10286 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2020 | 12280 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 57622 | 0.020 |
Why?
|
| Cholinergic Agonists | 1 | 2004 | 75 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2017 | 9513 | 0.020 |
Why?
|
| Age Factors | 1 | 2020 | 18159 | 0.010 |
Why?
|
| Incidence | 1 | 2021 | 20821 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2020 | 9193 | 0.010 |
Why?
|
| Aged | 3 | 2020 | 164457 | 0.010 |
Why?
|
| Calcium | 1 | 1994 | 5656 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2017 | 16668 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 11585 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 25194 | 0.010 |
Why?
|
| Prognosis | 1 | 2020 | 29078 | 0.010 |
Why?
|
| Cystic Fibrosis | 1 | 2003 | 1252 | 0.010 |
Why?
|
| Models, Biological | 1 | 2003 | 9460 | 0.000 |
Why?
|
| Adult | 1 | 2014 | 215288 | 0.000 |
Why?
|
Concepts
(181)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(22)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_